Acerus Provides Update on NATESTO® Approval Process in Europe
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that the dossier filed as a Decentralized Procedure…
Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP, OTCQB:ASPCF) today announced that the dossier filed as a Decentralized Procedure…
SAN FRANCISCO & NEW YORK–(BUSINESS WIRE)–$BMY—Nektar Therapeutics (Nasdaq:NKTR) and Bristol-Myers Squibb Company (NYSE:BMY) announced today the companies have agreed to…
DUBLIN–(BUSINESS WIRE)–The “Parenteral Nutrition Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026” report has been added…
With investors including Oskare Capital and Canopy Growth Cooperation founder Bruce Linton COPENHAGEN, Denmark–(BUSINESS WIRE)–#cannabinoids–Today, Octarine Bio IVS (“Octarine” or…
Data Presented at NASH-TAG Conference 2020 Showed over 90% Reduction in Plasma SSAO Activity After Single Dose Administrations of TERN-201…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global RNAi technology market since 2019 and the market is poised to grow by…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on January 8, 2020 the Compensation Committee of…
First quarter net revenues of $9.4 million reflecting 24.8% year-over-year growth Board of Directors announces quarterly dividend of $0.06 per…
NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company pioneering new innovations in neuromodulator products for aesthetic and therapeutic…
New interim analysis after third and final vaccination shows continued boosting of neutralizing antibody titers in both seronegative participants (exceeding…